Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PTEN-induced kinase 1 (PINK1) is a mitochondrial serine/threonine-protein kinase that plays a critical role in protecting cells from stress-induced mitochondrial dysfunction and is directly involved in mitochondrial quality control, particularly through mitophagy. It phosphorylates key substrates such as ubiquitin and Parkin’s ubiquitin-like domain to activate Parkin E3 ligase activity, which triggers tagging of damaged mitochondria for autophagic degradation. Mutations in PINK1 cause autosomal recessive early-onset Parkinson's disease.
Phosphorylation of ubiquitin and Parkin to activate Parkin E3 ligase activity, triggering mitophagy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PTEN-induced kinase 1 (PINK1).